We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+6.57%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$47.8B
AUM Growth
+$11.4B
(+31%)
Cap. Flow
+$7.61B
Cap. Flow
% of AUM
15.94%
Top 10 Holdings %
Top 10 Hldgs %
9.33%
Holding
2,816
New
319
Increased
937
Reduced
1,037
Closed
310
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$320M |
| 2 |
Gilead Sciences
GILD
|
+$266M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$213M |
| 4 |
TE Connectivity
TEL
|
+$179M |
| 5 |
Merck
MRK
|
+$179M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SHPG
Shire pic
SHPG
|
+$211M |
| 2 |
CNVR
CONVERSANT INC COM STK (DE)
CNVR
|
+$117M |
| 3 |
EOG Resources
EOG
|
+$106M |
| 4 |
CNQR
CONCUR TECHNOLOGIES INC
CNQR
|
+$102M |
| 5 |
CPWR
COMPUWARE CORP
CPWR
|
+$99.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.14% |
| 2 | Technology | 13.98% |
| 3 | Financials | 11.82% |
| 4 | Industrials | 9.05% |
| 5 | Consumer Discretionary | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELX
851
DELISTED
EMULEX CORP
ELX
| $5.09M | 0.01% |
898,392
+574,275
| +177% | +$3.09M |
|
852
Fair Isaac
FICO
$22.5B
| $5.06M | 0.01% |
69,956
-630
| -0.9% | -$41.4K |
|
|
NPSP
853
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $5.05M | 0.01% |
141,291
-52,460
| -27% | -$1.57M |
|
|
AVG
854
DELISTED
AVG Technologies N.V.
AVG
| $5.03M | 0.01% |
+254,903
| New | +$4.71M |
|
|
TESO
855
DELISTED
Tesco Corp
TESO
| $5.02M | 0.01% |
391,368
-157,034
| -29% | -$2.46M |
|
|
IBCA
856
DELISTED
INTERVEST BANCSHARES CORP COM
IBCA
| $4.97M | 0.01% |
495,072
| – | – |
|
|
ARIA
857
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $4.96M | 0.01% |
722,296
-721,418
| -50% | -$4.51M |
|
858
Gildan
GIL
$10.6B
| $4.96M | 0.01% |
+174,754
| New | +$4.98M |
|
859
Eaton
ETN
$174B
| $4.94M | 0.01% |
+72,672
| New | +$4.79M |
|
860
Entravision Communication
EVC
$1.1B
| $4.93M | 0.01% |
760,762
+177,782
| +30% | +$1M |
|
|
VAL
861
DELISTED
Valspar
VAL
| $4.92M | 0.01% |
56,945
-11,667
| -17% | -$957K |
|
|
PTRY
862
DELISTED
PANTRY INC (THE)
PTRY
| $4.9M | 0.01% |
132,293
+121,995
| +1,185% | +$3.29M |
|
863
DexCom
DXCM
$32B
| $4.89M | 0.01% |
355,496
-238,632
| -40% | -$2.92M |
|
864
Avis
CAR
$5.02B
| $4.88M | 0.01% |
73,501
-3,504
| -5% | -$200K |
|
865
Caleres
CAL
$487M
| $4.87M | 0.01% |
151,456
-22,230
| -13% | -$645K |
|
866
Cato Corp
CATO
$66.1M
| $4.86M | 0.01% |
115,198
+39,228
| +52% | +$1.47M |
|
867
Medifast
MED
$141M
| $4.86M | 0.01% |
144,763
+57,022
| +65% | +$1.78M |
|
868
Idacorp
IDA
$8.2B
| $4.85M | 0.01% |
73,254
+6,070
| +9% | +$372K |
|
|
EDE
869
DELISTED
Empire District Electric
EDE
| $4.84M | 0.01% |
162,909
+44,909
| +38% | +$1.24M |
|
|
NTUS
870
DELISTED
Natus Medical Inc
NTUS
| $4.79M | 0.01% |
132,787
+23,587
| +22% | +$792K |
|
871
Intuitive Surgical
ISRG
$134B
| $4.77M | 0.01% |
81,144
+61,020
| +303% | +$3.4M |
|
872
IDEX
IEX
$17.3B
| $4.76M | 0.01% |
61,169
+3,799
| +7% | +$283K |
|
|
SYA
873
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $4.74M | 0.01% |
205,548
+3,635
| +2% | +$82.7K |
|
874
Digital Realty Trust
DLR
$71.7B
| $4.74M | 0.01% |
71,430
+34,135
| +92% | +$2.28M |
|
|
FNHC
875
DELISTED
FedNat Holding Company Common Stock
FNHC
| $4.72M | 0.01% |
195,490
+115,590
| +145% | +$3.15M |
|
Similar funds
VGA
AQR Capital Management's Q4 2014 Portfolio in Review
As of Q4 2014, AQR Capital Management held 2,816 positions worth $47.8B, up 31% from $36.4B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
AQR Capital Management deployed $7.61B of net new capital in Q4 2014, opening 319 new positions and adding to 937 existing holdings. Its largest new stake was LyondellBasell Industries: 3,695,296 shares worth $293M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was EOG Resources, an estimated $106M trimmed.
- AQR Capital Management's largest Q4 2014 buy was LyondellBasell Industries: 3,695,296 shares worth $293M.
- AQR Capital Management added most to Gilead Sciences in Q4 2014, an estimated $266M increase.
- AQR Capital Management's biggest Q4 2014 reduction was EOG Resources, cutting an estimated $106M.
- AQR Capital Management fully exited Shire pic in Q4 2014, selling an estimated $211M.
- AQR Capital Management's ten largest holdings make up 9.3% of its $47.8B portfolio in Q4 2014.
- AQR Capital Management opened 319 new positions and closed 310 in Q4 2014.
- AQR Capital Management's portfolio value rose 31% quarter-over-quarter to $47.8B.
Based on AQR Capital Management's 13F filing for Q4 2014, filed 17 Feb 2015.